Related Experiment Video
Updated: Jun 19, 2025

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
Published on: May 21, 2018
BiRNN-DDI: A Drug-Drug Interaction Event Type Prediction Model Based on Bidirectional Recurrent Neural Network and
GuiShen Wang1, Hui Feng1, Chen Cao2
1School of Computer Science and Engineering, Changchun University of Technology, Changchun, China.
Abstract:
Research on drug-drug interaction (DDI) prediction, particularly in identifying DDI event types, is crucial for understanding adverse drug reactions and drug combinations. This work introduces a Bidirectional Recurrent Neural Network model for DDI event type prediction (BiRNN-DDI), which simultaneously considers structural relationships and contextual information. Our BiRNN-DDI model constructs drug feature graphs to mine structural relationships. For contextual information, it transforms drug graphs into sequences and employs a two-channel structure, integrating BiRNN, to obtain contextual representations of drug-drug pairs. The model's effectiveness is demonstrated through comparisons with state-of-the-art models on two DDI event-type benchmarks. Extensive experimental results reveal that BiRNN-DDI surpasses other models in accuracy, AUPR, AUC, F1 score, Precision, and Recall metrics on both small and large datasets. Additionally, our model exhibits a lower parameter space, indicating more efficient learning of drug feature representations and prediction of potential DDI event types.
Related Concept Videos
Drug-Receptor Interactions
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
The Two-State Receptor Model
The binding affinity of a drug determines its interaction with...
Drug-Receptor Interaction: Antagonist
Antagonists can be classified as competitive or noncompetitive based on their...
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Drug-Receptor Interaction: Agonist
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...

